These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

Swiss biotech Bioversys AG shares started trading at 36.5 Swiss francs ($40.29) on the SIX Swiss Exchange on Friday, slightly up from the final price for its initial public offering (IPO) of 36 Swiss ...

With approximately 60 to 70 million Americans currently affected by digestive health concerns including gastrointestinal (GI) intolerances and sensitivities, gut health has become a focal point in ...

RedHill Biopharma Ltd (RDHL) reported its Q1 2022 earnings, revealing a decrease in net revenues to $18.2 million from $22.1 million in the previous quarter. Despite this, the company achieved a gross ...